Vital Farms stock gained 2.10 percent ahead of November results
Vital Farms (VITL) stock rose 2.10% to USD 9.25 on October 5, 2026, ahead of its Q3 earnings report expected on November 5. This gain occurred despite the company's difficult Q2 2026 performance, which saw a 10.1% decline in revenue and a net loss of USD 31.07 million. Analysts hold a consensus "Hold" rating with an average 12-month price target of USD 17.18, suggesting potential upside.
Jefferies keeps Buy rating on Vital Farms stock
Jefferies has maintained a Buy rating and a $15.00 price target for Vital Farms (VITL) despite the company reporting a sharp deterioration in its second-quarter earnings. Vital Farms experienced a 10.20% revenue decrease to $166.03 million and a GAAP net loss of $31.07 million, compared to a profit in the prior year. The analyst support comes amidst operating pressure, with the stock's market capitalization at $388.2 million as of October 2, 2026.
(VITL) Volatility Zones as Tactical Triggers
This article provides an AI-driven analysis of Vital Farms Inc. (NASDAQ: VITL), identifying weak sentiment across all horizons and suggesting a short bias. It highlights an exceptional risk-reward short setup and outlines three distinct trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, complete with entry, target, and stop-loss zones. The analysis includes multi-timeframe signal analysis indicating weak signals for near-term, mid-term, and long-term horizons.
Vital Farms weighs options as Jefferies keeps Buy on Vital Farms stock
Vital Farms (VITL) is exploring strategic options, including a possible sale, after reporting a 10.20% drop in second-quarter revenue to $166.03 million and a GAAP net loss of $31.07 million. Despite the operational challenges, Jefferies has maintained a Buy rating with a $15 price target on the stock. The company is anticipating a recovery driven by improved sales velocity, household acquisition, and distribution gains, with the next earnings report scheduled for November 5, 2026.
Beyond Meat, Vital Farms lead most shorted consumer staples stocks below $2B (GO:NASDAQ)
Beyond Meat (BYND) and Vital Farms (VITL) are leading the list of most shorted consumer staples stocks with market capitalizations below $2 billion. Short interest was particularly concentrated in the packaged foods, food retail, and brewing sectors for these smaller cap companies. Beyond Meat reported a short interest of 29.62%, while Vital Farms had 24.35%.
Vital Farms faces egg pricing pressure, says Jefferies
Jefferies has maintained its $15 price target on Vital Farms (NASDAQ:VITL), noting that easing egg prices and a rebuilding layer flock are creating pressure on the company despite strong demand for pasture-raised eggs. The broker highlighted that while the overall egg market is loosening, Vital Farms' volumes declined and its premium over conventional and private-label eggs is narrowing, although distribution gains are expected to provide future growth. Jefferies still views Vital Farms as a key player in the growing pasture-raised category.
Vital Farms, Inc. (VITL) Stock Price, News, Quote & History
This article provides a detailed financial overview of Vital Farms, Inc. (VITL), a food company specializing in shell eggs and butter. It includes real-time stock price data, historical performance charts, key financial metrics, earnings trends, and analyst ratings. The company's profile, sector, and industry are also highlighted.
Vital Farms, Inc. (VITL) stock price, news, quote and history
This article provides comprehensive financial information for Vital Farms, Inc. (VITL), including its current stock price, historical data, performance metrics, and analyst insights. It details the company's overview, products, and key financial highlights such as revenue and earnings trends. The report also includes valuation measures and comparisons to the S&P 500 benchmark.
Jefferies Maintains Vital Farms(VITL.US) With Buy Rating, Maintains Target Price $15
Jefferies has reiterated its Buy rating on Vital Farms (VITL.US) and maintained its target price of $15. This indicates a continued positive outlook from the firm regarding the company's stock performance.
Vital Farms stock falls 1.79 percent as Q2 losses widen
Vital Farms (VITL) stock fell 1.79 percent on September 24, 2026, closing at USD 10.13, following a 9 percent drop the previous day. This decline was prompted by widening Q2 2026 losses, with revenue down 10.1 percent year-over-year to USD 166 million and a net loss of USD 31.1 million. The company's weak profitability and negative operating margin highlight concerns over cost control, despite revenue exceeding analyst estimates.
Vital Farms (VITL) Falls More Steeply Than Broader Market: What Investors Need to Know
Vital Farms (VITL) stock closed down 2.76% at $10.03, underperforming the broader market. The company is projected to report a significant EPS decrease and a modest revenue decline in its upcoming earnings release. Analysts' estimates for Vital Farms have remained stagnant, leading to a Zacks Rank of #3 (Hold) for the stock.
Why Vital Farms (VITL) Shares Are Trading Lower Today
Shares of Vital Farms (VITL) are trading lower today after Axios reported on September 16 that the company is considering strategic alternatives, including a potential take-private transaction. This news follows a previous report that caused the stock to rise, indicating market volatility. Despite the recent decline, analysts have reiterated a Buy rating with a target valuation of $15 to $25 per share.
Vital Farms (VITL) executive reports tax share withholding
Vital Farms (VITL) Chief People Officer Reena Chauhan Van Hoven had 344 shares of Common Stock withheld on September 16, 2026, to cover a tax obligation, valued at $10.03 per share. Following this transaction, Van Hoven directly holds 25,483 shares, including those jointly held with her spouse. The transaction was not conducted under a Rule 10b5-1 trading plan.
Vital Farms CPO Reena Chauhan Van Hoven Reports Stock Share Disposition
Reena Chauhan Van Hoven, Chief People Officer of Vital Farms, Inc. (NASDAQ:VITL), reported the disposition of 344 shares of common stock on September 16, 2026. The shares were withheld by the issuer to cover tax obligations at a price of $10.03 per share. After the transaction, Van Hoven beneficially owns 25,483 shares, including joint holdings with her spouse.
Vital Farms shares rally as investors weigh possible sale
Vital Farms (VITL) shares rallied after reports indicated the company is exploring strategic options, including a potential sale or take-private transaction, with a targeted valuation of $15 to $25 per share. This consideration follows a challenging second quarter due to industry oversupply and higher costs. Despite these issues, management reported improved sales velocity and Jefferies reiterated a "buy" rating, anticipating recovery.
Kuehn Law Encourages Investors of Vital Farms, Inc. to Contact Law Firm
Kuehn Law, PLLC, a shareholder litigation law firm, is investigating Vital Farms, Inc. (NASDAQ: VITL) for potential breaches of fiduciary duties by its officers and directors. The investigation stems from a federal securities lawsuit alleging that Vital Farms misrepresented or failed to disclose critical issues related to its ERP system implementation, which led to shipment and production delays and negatively impacted its business. The law firm is encouraging investors who purchased VITL shares prior to May 08, 2025, to contact them.
Vital Farms shares rally as investors weigh possible sale
Vital Farms (VITL) shares increased after a report indicated the company is exploring strategic options, including a potential sale. The report cited a targeted valuation of $15 to $25 per share. Despite a challenging second quarter due to industry oversupply and higher costs, management expressed optimism about recovery, supported by new credit facilities and efforts to improve gross margins, leading Jefferies to reiterate a "buy" rating.
Vital Farms shares rally as investors weigh possible sale
Vital Farms (VITL) shares rose after a report indicated the company is exploring strategic options, including a possible sale or take-private transaction, targeting a valuation of $15 to $25 per share. Despite a difficult second quarter, the company aims for a 30% gross margin run rate by the fourth quarter, leading Jefferies to reiterate a "buy" rating with a $15 price target. Investors reacted positively to the news, driving shares up by over 10% on Thursday afternoon.
3 Reasons to Avoid VITL and 1 Stock to Buy Instead
Vital Farms (VITL) has seen a significant stock price drop, leading analysts to warn against investment due to shrinking operating margins, declining EPS, and dropping free cash flow margins. The company's profitability has decreased even as revenue grew, and it currently trades at a valuation that suggests good news is already priced in. Instead, the article suggests looking for opportunities in the most dominant software businesses.
(VITL) Risk Channels and Responsive Allocation
Vital Farms Inc. (NASDAQ: VITL) shows weak sentiment across all time horizons, supporting a short bias. The analysis provides three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels. Despite weak sentiment, the absence of resistance levels above the current price suggests compelling upside potential.
VITL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Vital Farms, Inc. Securities Lawsuit - Contact The Gross Law Firm
The Gross Law Firm has issued a shareholder alert for investors of Vital Farms, Inc. (NASDAQ: VITL) who purchased shares between May 8, 2025, and February 26, 2026. The lawsuit alleges that Vital Farms made misleading statements regarding its ERP implementation, which led to shipment delays and negative business impacts. Shareholders with losses are encouraged to contact the firm to potentially lead the class action, with a deadline to seek lead plaintiff appointment by May 26, 2026.
5 Best Butter Brands, According to Chefs
Chefs recommend five top butter brands for various culinary uses, highlighting their unique flavors and textures. The article features brands like Vital Farms for its rich flavor, I Can’t Believe It’s Not Butter Extra Creamy for its sweetness, Kerrygold for its high fat content, Plugrà for its rich European-style taste, and Strauss Unsalted for control over seasoning. These selections cater to different preferences, from pasture-raised to high butterfat and unsalted options.
Analysts Estimate Vital Farms (VITL) to Report a Decline in Earnings: What to Look Out for
Analysts are forecasting a significant year-over-year decline in Vital Farms' (VITL) earnings and revenues for the quarter ended June 2026, with an expected loss of $0.45 per share and a 7.4% revenue drop. The company currently holds a Zacks Rank #5 (Strong Sell) and a negative Earnings ESP of -2.57%, making an earnings beat unlikely. Investors are advised to consider other factors beyond just the earnings report when evaluating the stock.
Vital Farms: The Recovery Is Starting, But I Need More Proof (NASDAQ:VITL)
Vital Farms (VITL) reported a challenging Q2 with a 10% revenue decline and a significant drop in gross margin to 6.6%, alongside substantial cash burn. Despite this, the company beat revenue expectations and reaffirmed full-year guidance, showing initial signs of stabilization in price gaps and supply. While management anticipates gross margin recovery to around 30% by Q4, a return to historical 35-40% margins is deemed unlikely, leading the analyst to maintain a Hold rating pending further proof of sustained improvement.
Vital Farms : VITL
This article provides an overview of Vital Farms Inc. (VITL), an Austin, Texas-based food company known for its commitment to ethical farming practices and pasture-raised products. It includes stock data for VITL, showing its current trading price and sector, and lists one related article discussing Beyond Meat's stock performance. The page also features other trending financial articles.
Form 8K Vital Farms Inc For: 17 August By Investing.com
This article reports on a Form 8K filing by Vital Farms Inc. on August 17. The filing is a standard disclosure required by the SEC for significant events. The article provides the company's stock symbol (VITL) and its current performance.
Vital Farms : VITL
This article provides an overview of Vital Farms Inc (VITL), an Austin, Texas-based food company known for its ethical farming practices and pasture-raised products like eggs and butter. It includes current stock data for VITL, showing a price of $10.98, and lists a related article discussing Beyond Meat's stock performance. The page also features trending articles on various financial and economic topics.
Vital Farms amends 8-K to add missing Item 5.03 in EDGAR header
Vital Farms has filed an amended Form 8-K to correct a minor omission in its EDGAR header. The amendment specifically adds the missing Item 5.03 reference, with no other changes made to the original filing. This correction relates to the company's adoption of amended and restated bylaws that became effective on August 11, 2026.
Form 8K Vital Farms Inc For: 17 August By Investing.com
This article reports on Vital Farms Inc.'s Form
ETFs Investing in Vital Farms, Inc. Stocks
This article lists Exchange Traded Funds (ETFs) that hold Vital Farms, Inc. (5KH) stocks, providing investors with options to gain exposure to the company. The list includes details such as market value, weight, issuer, management style, expense ratio, assets under management (AUM), and price performance for each ETF. These ETFs offer opportunities for diversified investing in Vital Farms, Inc. with potentially lower risk.
VITL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Vital Farms, Inc. (NASDAQ:VITL) and some of its officers. The lawsuit alleges that Vital Farms made false and misleading statements regarding delays and impact of its new enterprise resource planning (ERP) system, leading to missed full-year earnings guidance. Investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, are encouraged to join the lawsuit by May 26, 2026, to request lead plaintiff status.
Vital Farms (NASDAQ:VITL) Upgraded at Zacks Research
Zacks Research upgraded Vital Farms (NASDAQ:VITL) from a "strong sell" to a "hold" rating, while the average analyst consensus remains "hold" with a $17.18 price target. The company reported quarterly revenue of $166.03 million, exceeding estimates, but experienced a 10.2% year-over-year revenue decline and an adjusted loss of $0.47 per share. Insiders purchased 35,700 shares, and institutional investors hold a significant 98.59% of the stock.
Vital Farms, Inc.'s Equity Buyback announced on February 26, 2026, has expired.
Vital Farms, Inc. (VITL) announced that its equity buyback plan, originally disclosed on February 26, 2026, expired on August 3, 2026. This news comes amidst recent analyst upgrades, earnings reports, and guidance reiterations from the company.
Needham & Company LLC Issues Positive Forecast for Vital Farms (NASDAQ:VITL) Stock Price
Needham & Company LLC has raised its price target for Vital Farms (NASDAQ:VITL) to $14 from $13, maintaining a "buy" rating and indicating a potential upside of 11.76%. This positive forecast comes despite mixed analyst sentiment, with the company reporting a quarterly loss of $0.47 per share and a 10.2% year-over-year revenue decline, even as revenue exceeded consensus estimates. Insider buying and increased institutional ownership are noted, alongside an average "Hold" rating from analysts with a consensus price target of $21.25.
Vital Farms, Inc. Stock 12‑Month Price Target Raised to $12.89, Implies 5% Upside
Vital Farms, Inc.'s average stock price target has increased to $12.89 from $12, according to estimates from nine analysts, with forecasts ranging from $10 to $18 per share. This updated target suggests a potential upside of approximately 5% based on the August 5 closing price. The consensus rating for VITL remains "Buy" among ten covering analysts, with four recommending "Buy" and six recommending "Hold."
Dimensional Fund Advisors LP Purchases 447,728 Shares of Vital Farms, Inc. $VITL
Dimensional Fund Advisors LP increased its stake in Vital Farms, Inc. by 46.8% in the first quarter, purchasing an additional 447,728 shares. This makes their total holding 1,405,032 shares, valued at $19.836 million. The article also notes recent insider buying activity and mixed analyst sentiment on Vital Farms, despite the company reporting second-quarter revenue that topped expectations.
Vital Farms, Inc. Q2 2026: Revenue $166M, Net income $(31.1)M — 10-Q Summary
Vital Farms, Inc. (VITL) reported its Q2 2026 financial results, showing a revenue of $166 million, a 10% decrease year-over-year, and a net loss of $(31.1) million, a significant drop from the previous year's net income. The company is facing challenges due to oversupply leading to lower prices and has implemented operational changes including workforce reduction, halting farm builds, and winding down a butter line to focus on core egg products. Despite these challenges, Vital Farms maintains its position as a leading pasture-raised egg brand with high household penetration.
Why Vital Farms (VITL) Stock Is Up Today
Shares of Vital Farms (VITL) rose by 3.9% despite the company reporting a disappointing second quarter with a significant revenue drop and a net loss. The poor performance was attributed to a massive contraction in gross margin, although the company reaffirmed its full-year revenue guidance. The stock has been volatile, and its current price is significantly below its 52-week high, indicating investor concern about its future amidst inflationary pressures and rising input costs.
VITL Q2 FY2026 earnings call
Vital Farms (VITL) reported a 10.1% year-over-year net revenue decline in Q2 FY2026 to $166.0 million, with a significant adjusted EBITDA loss of $26.6 million, attributing the results to industry-wide egg oversupply and price-gap challenges. Despite the downturn, management reaffirmed full-year guidance for net revenue between $775-800 million and adjusted EBITDA of $0-10 million, citing decisive actions such as farmer contract amendments, narrowed price gaps, and SG&A reductions. The company anticipates sequential improvement in Q3 and expects to exit Q4 with a 30% gross margin, driven by distribution gains and cost savings initiatives, while pausing construction on a major facility to conserve capital.
Vital Farms (NASDAQ:VITL) Rating Increased to Buy at Benchmark
Benchmark has upgraded Vital Farms (NASDAQ:VITL) from a "hold" to a "buy" rating, despite the broader analyst consensus remaining "hold" with an average price target of $24.08. Vital Farms' shares rose 1.0% to $12.37, though this is significantly below its 12-month high of $53.13. The company reported quarterly revenue of $166.03 million, exceeding expectations, but experienced a 10.2% year-over-year decline.
Earnings call transcript: Vital Farms misses Q2 2026 estimates as shares fall
Vital Farms (VITL) reported a wider-than-expected Q2 2026 loss and lower revenue, missing analyst estimates due to industry oversupply, higher supply-management costs, and one-time turnaround expenses. Shares fell over 6% following the announcement, trading well below their 52-week high. Despite the miss, management reaffirmed full-year guidance, anticipating a financial trough in Q2 and sequential improvement in the second half of 2026 driven by narrower price gaps, distribution gains, and cost reductions.
Vital Farms (VITL) Reports Q2 Loss, Beats Revenue Estimates
Vital Farms (VITL) reported a Q2 loss of $0.47 per share, slightly wider than the Zacks Consensus Estimate of a $0.46 loss, contrasting with earnings of $0.36 per share a year ago. However, the company surpassed revenue estimates, posting $166.03 million against a consensus of $165.61 million. Despite beating revenue, the stock has underperformed the market significantly this year, and its current Zacks Rank #4 (Sell) suggests expected underperformance in the near future.
Silver Point Leads $125 Million Term Loan Financing for Vital Farms
Silver Point Capital's Direct Lending business has led a $125 million term loan financing for Vital Farms (Nasdaq: VITL), a Certified B Corporation known for ethically produced foods. This financing, alongside a new asset-based revolving credit facility from J.P. Morgan, will provide Vital Farms with additional liquidity to support its next phase of growth. Silver Point will act as the sole lender and administrative agent for the term loan.
Vital Farms Q2 2026 earnings: Egg oversupply cuts gross margin to 6.6%
Vital Farms (NASDAQ: VITL) reported a significant decline in its Q2 2026 financial performance, with net revenue down 10.1% and diluted EPS swinging to a $0.72 loss. The primary driver for this downturn was an egg oversupply, which led to lower-priced channel sales and a contraction in gross margin to 6.6% from 38.9%. Despite these challenges, the company reiterated its fiscal 2026 revenue and adjusted EBITDA guidance, banking on improved shell egg volume and cost-saving initiatives in the second half of the year.
Egg oversupply drives Vital Farms to a $31.1M Q2 loss
Vital Farms (Nasdaq: VITL) reported a Q2 2026 net loss of $31.1 million, a significant drop from a net income of $16.6 million in Q2 2025, primarily due to industry-wide egg oversupply and lower retail prices. Despite a 10.1% decrease in net revenue to $166.0 million, the company successfully grew its dollar share in the shell egg category by over 200 basis points. Vital Farms has implemented a recovery plan, including supply control and cost-saving initiatives, and secured new credit facilities totaling $185 million, while reiterating its fiscal year 2026 net revenue outlook of $775 million to $800 million.
Insiders Could Have Profited By Holding onto Vital Farms Shares Despite 11% Drop
Vital Farms (NASDAQ:VITL) has seen its stock drop by 11% recently. Insiders who sold US$18 million worth of shares over the past year at an average price of US$50.78 would have been better off holding, as the current share price is US$12.15. Despite this, insiders have bought US$422k worth of shares in the last quarter, indicating confidence and strong insider ownership.
Bronstein, Gewirtz & Grossman, LLC Encourages Vital Farms, Inc. (VITL) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Vital Farms, Inc. (NASDAQ:VITL) regarding alleged corporate wrongdoing. The firm encourages investors who purchased Vital Farms securities before May 8, 2025, and still hold them, to contact them for more information and to assist in the investigation. The representation of investors in class actions is on a contingency fee basis.
Vital Farms (VITL) Reports Q2: Everything You Need To Know Ahead Of Earnings
Vital Farms (VITL), an egg and butter company, is scheduled to report its Q2 earnings this Thursday morning. The market anticipates a 10.8% year-on-year revenue decline, a reversal from the previous year's increase, and analysts have largely maintained their estimates. Despite Vital Farms' stock being down 5.1% over the last month, the broader perishable food segment has seen positive investor sentiment.
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Class A
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Vital Farms, Inc. (NASDAQ:VITL) and certain officers, alleging federal securities law violations. The lawsuit claims Vital Farms made misleading statements regarding delays in its new ERP system rollout, which caused the company to miss its 2025 earnings guidance. Investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, are encouraged to join the suit, with a lead plaintiff deadline of May 26, 2026.
VITL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vital Farms, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Vital Farms, Inc. (NASDAQ:VITL) on behalf of investors who suffered losses from May 8, 2025, to February 26, 2026. The lawsuit alleges that Vital Farms made false and misleading statements regarding delays and impacts related to its new ERP system, causing the company to miss its full-year 2025 earnings guidance. Investors have until May 26, 2026, to request to be appointed as lead plaintiff in the case.
